Research summary ·
Clinical efficacy of deep brain stimulation for psychiatric and neurological indications on a meta-analytic level.
Written based on 1 research study on PubMed, searched on 3 Nov 2026.
What was studied
This review pooled trials of deep brain stimulation, or DBS. Trials compared real DBS with sham DBS in a blinded way. They covered OCD, major depression and Tourette syndrome. They also covered Parkinson's disease, essential tremor, dystonia and epilepsy. The review compared 28 studies.
What they found
Effects were largest in essential tremor. In psychiatry, they were largest in Tourette syndrome. Major depression and epilepsy showed no significant effect. The SMD was -1.42 for essential tremor. It was -1.22 for Tourette syndrome. It was -0.72 for OCD. It was -0.71 for dystonia. It was 0.74 for Parkinson's disease. It was -0.22 for major depression. It was -0.09 for epilepsy.
What it means for patients
The authors say wider use of DBS for OCD and Tourette syndrome is justifiable. DBS is used for movement disorders. It is rarely used for psychiatric ones.
Why it is not certain yet
The abstract does not say how many studies covered each condition. It gives no long-term results. Results differ by condition.
Source
Clinical efficacy of deep brain stimulation for psychiatric and neurological indications on a meta-analytic level.
PubMed · PMID 42550465We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Tourette syndrome publications